Previous 10 | Next 10 |
home / stock / pfe / pfe articles
Pfizer Inc (NYSE: PFE) is turning its focus to the weight loss drug market, aiming to capture a $10 billion segment with its experimental obes...
Saint-Herblain (France), November 7, 2023 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that its senior ma...
BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago...
Pfizer Inc (NYSE: PFE) reported a loss for the third quarter on Tuesday. Pfizer reported a quarterly adjusted EPS loss of 17 cents versus a consens...
Pfizer Inc (NYSE: PFE) reported a loss for the third quarter on Tuesday. Pfizer reported a quarterly adjusted EPS loss of 17 cents versus a consens...
Risk sentiment has encountered a setback following Monday’s rally, as stocks on Wall Street grapple with challenges in generating fresh gains...
U.S. stocks traded lower this morning, following the release of economic reports. Following the market opening Tuesday, the Dow traded down 0.25% t...
Pfizer Inc (NYSE: PFE) has reported a Q3 adjusted EPS loss of $(0.17) versus a consensus loss of $(0.32), down from EPS income of $0.67 i...
Early indications suggest U.S. stock could strive to retain the winning momentum intact, although key catalysts scheduled for the next couple of se...
News, Short Squeeze, Breakout and More Instantly...
2024-07-25 06:15:00 ET If you're looking to invest in order to get richer, that's great -- because most of us need to be amassing a war chest for retirement (not to mention other financial goals, such as a down payment for a home and college tuition for kids). The simplest, and arguably bes...
2024-07-25 05:05:00 ET Which company is the leader in the burgeoning weight loss drug market? A recent poll found that among the largest drugmakers, Pfizer (NYSE: PFE) is the one Americans associate most with this therapeutic area. That's a surprising finding: Pfizer does not ha...
2024-07-24 10:13:00 ET If there's one thing healthcare giant Pfizer (NYSE: PFE) really needs right now, it's a compelling growth catalyst. This year, the company isn't expecting much in the way of growth and investors are unsure about how strong its long-term prospects are, which ...